(Q26344305)

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

Field evaluation of a hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Clinical trials of varicella vaccine in healthy adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Antimicrobial treatment of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Transmission of the human immunodeficiency virus in the health care setting--time for action

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Who should receive hepatitis A vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Nosocomial pertussis in the nineties

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Comparison of values of antibody to Bordetella pertussis antigens in young German and American men

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Transmission of human immunodeficiency virus in a dental practice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Frequency of unrecognized Bordetella pertussis infections in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Pertussis in an adult man infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

An outbreak of hepatitis A among health care workers: risk factors for transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Adult immunization with acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Expected costs of implementing a mandatory human immunodeficiency virus and hepatitis B virus testing and restriction program for healthcare workers performing invasive procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Varicella Vaccine: The American Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

The varicella vaccine. Clinical trials in immunocompromised individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Acellular pertussis vaccine in adults: adverse reactions and immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Epidemic streptococcal disease among Army trainees, July 1989 through June 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Support for dental HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Risks to surgeons and patients from HIV and hepatitis: guidelines on precautions and management of exposure to blood or body fluids. Joint Working Party of the Hospital Infection Society and the Surgical Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Nosocomial tuberculosis: new progress in control and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Screening surgeons for HIV infection. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Intrauterine Infection with Varicella-Zoster Virus after Maternal Varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Epidemiology and prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Investigations of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Pertussis infection among adults during the 1993 outbreak in Chicago

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

A second look at the cost of mandatory human immunodeficiency virus and hepatitis B virus testing for healthcare workers performing invasive procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Trial of a new acellular pertussis vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Development of an acellular pertussis vaccine and its administration as a booster in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

The varicella vaccine. Vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Management of healthcare workers exposed to pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Management of the Healthcare Worker Infected with Human Immunodeficiency Virus: Lessons from Nosocomial Transmission of Hepatitis B Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

THE EPIDEMIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021

Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970358-5

7 January 2021